search
Back to results

Progesterone Effect on Individuals Diagnoses With AD and PTSD.

Primary Purpose

Alcohol Dependence, Post-Traumatic Stress Disorder (PTSD)

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Progesterone
Placebo (for Progesterone)
Sponsored by
Yale University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Alcohol Dependence focused on measuring Alcohol Dependence, Post-Traumatic stress disorder (PTSD), Progesterone

Eligibility Criteria

21 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Men and women ages 18 to 45;
  2. Current diagnosis of AD and PTSD;
  3. Drink regularly are not in an active phase of alcohol withdrawal;
  4. Not at risk for suicide;
  5. Not taking regularly psychoactive drugs including anxiolytics and antidepressants;
  6. For women, have regular menses every 25-35 days.

Exclusion Criteria:

  1. Current SCID diagnosis of any psychotic disorder;
  2. Substance dependence (other than alcohol and nicotine) in the past 30 days;
  3. Current unstable medical condition;
  4. Positive test results at more than one baseline appointment on urine drug screens conducted for opiates, cocaine, marijuana, benzodiazepines, and barbiturates; for women, amenorrhea, use of oral contraceptives;
  5. Known allergy to progesterone or peanuts (vehicle for micronized progesterone);
  6. History of thrombophlebitis, deep vein thrombosis, pulmonary embolus, clotting or Bleeding disorders, heart disease, diabetes or history of stroke.

Sites / Locations

  • VA Connecticut Healtcase System

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Progesterone

Placebo

Arm Description

For the three days prior to each test day every participant in this arm will receive one progesterone capsule (200 mg. bid) on the first day and 2 progesterone capsules per day for days 2 and 3. On the test day the participant will receive the last progesterone capsule (200 mg.bid). On the test day two scripts will be read one trauma related script (most traumatic experience) and one neutral script (relaxed scene given by participant)

For the three days prior to each test day every participant in this arm will receive one placebo capsule on the first day and 2 placebo capsules per day for days 2 and 3. On the test day the participant will receive the last placebo capsule. On the test day two scripts will be read one trauma related script (most traumatic experience) and one neutral script (relaxed scene given by participant)

Outcomes

Primary Outcome Measures

Visual Analogue Scale of Craving (VASC) Baseline no Script
Visual Analogue Scale of Craving (VASC) is a self-report rating scale using the Likert scale (0 Not at all carving alcohol - 10 Extremely carving alcohol)
Visual Analogue Scale of Craving (VASC) 10 Minutes (Pre-script #1)
Visual Analogue Scale of Craving (VASC) is a self-report rating scale using the Likert scale (0 Not at all carving alcohol - 10 Extremely carving alcohol)
Visual Analogue Scale of Craving (VASC) 25 Minutes (Post-Script #1)
Visual Analogue Scale of Craving (VASC) is a self-report rating scale using the Likert scale (0 Not at all carving alcohol - 10 Extremely carving alcohol)
Visual Analogue Scale of Craving (VASC) 40 Minutes (Post-Recovery #1)
Visual Analogue Scale of Craving (VASC) is a self-report rating scale using the Likert scale (0 Not at all carving alcohol - 10 Extremely carving alcohol)
Visual Analogue Scale of Craving (VASC) 65 Minutes (Pre-Script #2)
Visual Analogue Scale of Craving (VASC) is a self-report rating scale using the Likert scale (0 Not at all carving alcohol - 10 Extremely carving alcohol)
Visual Analogue Scale of Craving (VASC) 80 Minutes (Post-Script #2)
Visual Analogue Scale of Craving (VASC) is a self-report rating scale using the Likert scale (0 Not at all carving alcohol - 10 Extremely carving alcohol)
Visual Analogue Scale of Craving (VASC) 95 Minutes (Post-Recovery #2)
Visual Analogue Scale of Craving (VASC) is a self-report rating scale using the Likert scale (0 Not at all carving alcohol - 10 Extremely carving alcohol)
Visual Analogue Scale of Anxiety (VASA) Baseline no Script
Visual Analogue Scale of Anxiety (VASA) is a self-report rating scale using the Likert scale (0 Not at all Anxious - 10 Extremely Anxious)
Visual Analogue Scale of Anxiety (VASA) 10 Minutes (Pre-Script #1)
Visual Analogue Scale of Anxiety (VASA) is a self-report rating scale using the Likert scale (0 Not at all Anxious - 10 Extremely Anxious)
Visual Analogue Scale of Anxiety (VASA) 25 Minutes (Post-Script #1)
Visual Analogue Scale of Anxiety (VASA) is a self-report rating scale using the Likert scale (0 Not at all Anxious - 10 Extremely Anxious)
Visual Analogue Scale of Anxiety (VASA) 40 Minutes (Post-Recovery #1)
Visual Analogue Scale of Anxiety (VASA) is a self-report rating scale using the Likert scale (0 Not at all Anxious - 10 Extremely Anxious)
Visual Analogue Scale of Anxiety (VASA) 65 Minutes (Pre-Script #2)
Visual Analogue Scale of Anxiety (VASA) is a self-report rating scale using the Likert scale (0 Not at all Anxious - 10 Extremely Anxious)
Visual Analogue Scale of Anxiety (VASA) 80 Minutes (Post-Script #2)
Visual Analogue Scale of Anxiety (VASA) is a self-report rating scale using the Likert scale (0 Not at all Anxious - 10 Extremely Anxious)
Visual Analogue Scale of Anxiety (VASA) 95 Minutes (Post-Recovery #2)
Visual Analogue Scale of Anxiety (VASA) is a self-report rating scale using the Likert scale (0 Not at all Anxious - 10 Extremely Anxious)

Secondary Outcome Measures

State Trait Anxiety Inventory (STAI-6) Baseline no Script
Six-item State-Trait Anxiety Inventory (STAI-6) is a psychological inventory consisting of 6 self-report items on a 4-point Likert scale. The STAI-6 measures state anxiety. Higher scores are positively correlated with higher levels of anxiety. STAI-6 scores are classified as "no or low anxiety" (6-12), "moderate anxiety" (13-18), and "high anxiety" (19-24). (minimum score of 6 to a maximum score of 24)
Six-item State-Trait Anxiety Inventory (STAI-6) 10 Minutes (Pre-Script #1)
Six-item State-Trait Anxiety Inventory (STAI-6) is a psychological inventory consisting of 6 self-report items on a 4-point Likert scale. The STAI-6 measures state anxiety. Higher scores are positively correlated with higher levels of anxiety. STAI-6 scores are classified as "no or low anxiety" (6-12), "moderate anxiety" (13-18), and "high anxiety" (19-24). (minimum score of 6 to a maximum score of 24)
Six-item State-Trait Anxiety Inventory (STAI-6) 25 Minutes (Post-Script #1)
Six-item State-Trait Anxiety Inventory (STAI-6) is a psychological inventory consisting of 6 self-report items on a 4-point Likert scale. The STAI-6 measures state anxiety. Higher scores are positively correlated with higher levels of anxiety. STAI-6 scores are classified as "no or low anxiety" (6-12), "moderate anxiety" (13-18), and "high anxiety" (19-24). (minimum score of 6 to a maximum score of 24)
Six-item State-Trait Anxiety Inventory (STAI-6) 40 Minutes (Post-Recovery #1)
Six-item State-Trait Anxiety Inventory (STAI-6) is a psychological inventory consisting of 6 self-report items on a 4-point Likert scale. The STAI-6 measures state anxiety. Higher scores are positively correlated with higher levels of anxiety. STAI-6 scores are classified as "no or low anxiety" (6-12), "moderate anxiety" (13-18), and "high anxiety" (19-24). (minimum score of 6 to a maximum score of 24)
Six-item State-Trait Anxiety Inventory (STAI-6) 65 Minutes (Pre-Script #2)
Six-item State-Trait Anxiety Inventory (STAI-6) is a psychological inventory consisting of 6 self-report items on a 4-point Likert scale. The STAI-6 measures state anxiety. Higher scores are positively correlated with higher levels of anxiety. STAI-6 scores are classified as "no or low anxiety" (6-12), "moderate anxiety" (13-18), and "high anxiety" (19-24). (minimum score of 6 to a maximum score of 24)
Six-item State-Trait Anxiety Inventory (STAI-6) 80 Minutes (Post-Script #2)
Six-item State-Trait Anxiety Inventory (STAI-6) is a psychological inventory consisting of 6 self-report items on a 4-point Likert scale. The STAI-6 measures state anxiety. Higher scores are positively correlated with higher levels of anxiety. STAI-6 scores are classified as "no or low anxiety" (6-12), "moderate anxiety" (13-18), and "high anxiety" (19-24). (minimum score of 6 to a maximum score of 24)
Six-item State-Trait Anxiety Inventory (STAI-6) (STAI-6) 95 Minutes (Post-Recovery #2)
Six-item State-Trait Anxiety Inventory (STAI-6) is a psychological inventory consisting of 6 self-report items on a 4-point Likert scale. The STAI-6 measures state anxiety. Higher scores are positively correlated with higher levels of anxiety. STAI-6 scores are classified as "no or low anxiety" (6-12), "moderate anxiety" (13-18), and "high anxiety" (19-24). (minimum score of 6 to a maximum score of 24)

Full Information

First Posted
July 8, 2014
Last Updated
April 3, 2023
Sponsor
Yale University
Collaborators
United States Department of Defense, Brain & Behavior Research Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT02187224
Brief Title
Progesterone Effect on Individuals Diagnoses With AD and PTSD.
Official Title
Progesterone Treatment in Reducing Trauma and Alcohol Induced Craving in Individuals Diagnoses With Alcohol Dependence (AD) and Post-tramatic Stress Disorder (PTSD).
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Completed
Study Start Date
September 1, 2016 (Actual)
Primary Completion Date
September 8, 2021 (Actual)
Study Completion Date
September 8, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Yale University
Collaborators
United States Department of Defense, Brain & Behavior Research Foundation

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a randomized control trial with an anticipated 36 participants diagnosed with post-traumatic stress disorder (PTSD) and comorbid alcohol dependence. Participants will be randomized to receive either progesterone (200 mg. bid) or placebo in identical looking capsules for three days. One goal of this research study is to test if progesterone is more effective than placebo in reducing craving after exposure to trauma cues and alcohol cues in a laboratory paradigm among men and women with AD and PTSD. We hypothesize that progesterone in comparison to placebo will significantly reduce craving for alcohol in response to trauma cues alone and in combination with alcohol cues in individuals with AD and PTSD. A second goal is to examine if there are gender differences in progesterone effects on stress and alcohol cue-induced craving. We hypothesize that the effects of progesterone on stress and craving will be stronger in women than in men. Participants will be recruited primarily through advertisement, but also through the clinical facilities at the VA and from other collaborators.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alcohol Dependence, Post-Traumatic Stress Disorder (PTSD)
Keywords
Alcohol Dependence, Post-Traumatic stress disorder (PTSD), Progesterone

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
13 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Progesterone
Arm Type
Experimental
Arm Description
For the three days prior to each test day every participant in this arm will receive one progesterone capsule (200 mg. bid) on the first day and 2 progesterone capsules per day for days 2 and 3. On the test day the participant will receive the last progesterone capsule (200 mg.bid). On the test day two scripts will be read one trauma related script (most traumatic experience) and one neutral script (relaxed scene given by participant)
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
For the three days prior to each test day every participant in this arm will receive one placebo capsule on the first day and 2 placebo capsules per day for days 2 and 3. On the test day the participant will receive the last placebo capsule. On the test day two scripts will be read one trauma related script (most traumatic experience) and one neutral script (relaxed scene given by participant)
Intervention Type
Drug
Intervention Name(s)
Progesterone
Intervention Type
Drug
Intervention Name(s)
Placebo (for Progesterone)
Primary Outcome Measure Information:
Title
Visual Analogue Scale of Craving (VASC) Baseline no Script
Description
Visual Analogue Scale of Craving (VASC) is a self-report rating scale using the Likert scale (0 Not at all carving alcohol - 10 Extremely carving alcohol)
Time Frame
Baseline
Title
Visual Analogue Scale of Craving (VASC) 10 Minutes (Pre-script #1)
Description
Visual Analogue Scale of Craving (VASC) is a self-report rating scale using the Likert scale (0 Not at all carving alcohol - 10 Extremely carving alcohol)
Time Frame
10 minutes
Title
Visual Analogue Scale of Craving (VASC) 25 Minutes (Post-Script #1)
Description
Visual Analogue Scale of Craving (VASC) is a self-report rating scale using the Likert scale (0 Not at all carving alcohol - 10 Extremely carving alcohol)
Time Frame
25 minutes
Title
Visual Analogue Scale of Craving (VASC) 40 Minutes (Post-Recovery #1)
Description
Visual Analogue Scale of Craving (VASC) is a self-report rating scale using the Likert scale (0 Not at all carving alcohol - 10 Extremely carving alcohol)
Time Frame
40 minutes
Title
Visual Analogue Scale of Craving (VASC) 65 Minutes (Pre-Script #2)
Description
Visual Analogue Scale of Craving (VASC) is a self-report rating scale using the Likert scale (0 Not at all carving alcohol - 10 Extremely carving alcohol)
Time Frame
65 minutes
Title
Visual Analogue Scale of Craving (VASC) 80 Minutes (Post-Script #2)
Description
Visual Analogue Scale of Craving (VASC) is a self-report rating scale using the Likert scale (0 Not at all carving alcohol - 10 Extremely carving alcohol)
Time Frame
80 minutes
Title
Visual Analogue Scale of Craving (VASC) 95 Minutes (Post-Recovery #2)
Description
Visual Analogue Scale of Craving (VASC) is a self-report rating scale using the Likert scale (0 Not at all carving alcohol - 10 Extremely carving alcohol)
Time Frame
95 minutes
Title
Visual Analogue Scale of Anxiety (VASA) Baseline no Script
Description
Visual Analogue Scale of Anxiety (VASA) is a self-report rating scale using the Likert scale (0 Not at all Anxious - 10 Extremely Anxious)
Time Frame
Baseline
Title
Visual Analogue Scale of Anxiety (VASA) 10 Minutes (Pre-Script #1)
Description
Visual Analogue Scale of Anxiety (VASA) is a self-report rating scale using the Likert scale (0 Not at all Anxious - 10 Extremely Anxious)
Time Frame
10 minutes
Title
Visual Analogue Scale of Anxiety (VASA) 25 Minutes (Post-Script #1)
Description
Visual Analogue Scale of Anxiety (VASA) is a self-report rating scale using the Likert scale (0 Not at all Anxious - 10 Extremely Anxious)
Time Frame
25 minutes
Title
Visual Analogue Scale of Anxiety (VASA) 40 Minutes (Post-Recovery #1)
Description
Visual Analogue Scale of Anxiety (VASA) is a self-report rating scale using the Likert scale (0 Not at all Anxious - 10 Extremely Anxious)
Time Frame
40 minutes
Title
Visual Analogue Scale of Anxiety (VASA) 65 Minutes (Pre-Script #2)
Description
Visual Analogue Scale of Anxiety (VASA) is a self-report rating scale using the Likert scale (0 Not at all Anxious - 10 Extremely Anxious)
Time Frame
65 minutes
Title
Visual Analogue Scale of Anxiety (VASA) 80 Minutes (Post-Script #2)
Description
Visual Analogue Scale of Anxiety (VASA) is a self-report rating scale using the Likert scale (0 Not at all Anxious - 10 Extremely Anxious)
Time Frame
80 minutes
Title
Visual Analogue Scale of Anxiety (VASA) 95 Minutes (Post-Recovery #2)
Description
Visual Analogue Scale of Anxiety (VASA) is a self-report rating scale using the Likert scale (0 Not at all Anxious - 10 Extremely Anxious)
Time Frame
95 minutes
Secondary Outcome Measure Information:
Title
State Trait Anxiety Inventory (STAI-6) Baseline no Script
Description
Six-item State-Trait Anxiety Inventory (STAI-6) is a psychological inventory consisting of 6 self-report items on a 4-point Likert scale. The STAI-6 measures state anxiety. Higher scores are positively correlated with higher levels of anxiety. STAI-6 scores are classified as "no or low anxiety" (6-12), "moderate anxiety" (13-18), and "high anxiety" (19-24). (minimum score of 6 to a maximum score of 24)
Time Frame
Baseline
Title
Six-item State-Trait Anxiety Inventory (STAI-6) 10 Minutes (Pre-Script #1)
Description
Six-item State-Trait Anxiety Inventory (STAI-6) is a psychological inventory consisting of 6 self-report items on a 4-point Likert scale. The STAI-6 measures state anxiety. Higher scores are positively correlated with higher levels of anxiety. STAI-6 scores are classified as "no or low anxiety" (6-12), "moderate anxiety" (13-18), and "high anxiety" (19-24). (minimum score of 6 to a maximum score of 24)
Time Frame
10 minutes
Title
Six-item State-Trait Anxiety Inventory (STAI-6) 25 Minutes (Post-Script #1)
Description
Six-item State-Trait Anxiety Inventory (STAI-6) is a psychological inventory consisting of 6 self-report items on a 4-point Likert scale. The STAI-6 measures state anxiety. Higher scores are positively correlated with higher levels of anxiety. STAI-6 scores are classified as "no or low anxiety" (6-12), "moderate anxiety" (13-18), and "high anxiety" (19-24). (minimum score of 6 to a maximum score of 24)
Time Frame
25 minutes
Title
Six-item State-Trait Anxiety Inventory (STAI-6) 40 Minutes (Post-Recovery #1)
Description
Six-item State-Trait Anxiety Inventory (STAI-6) is a psychological inventory consisting of 6 self-report items on a 4-point Likert scale. The STAI-6 measures state anxiety. Higher scores are positively correlated with higher levels of anxiety. STAI-6 scores are classified as "no or low anxiety" (6-12), "moderate anxiety" (13-18), and "high anxiety" (19-24). (minimum score of 6 to a maximum score of 24)
Time Frame
40 minutes
Title
Six-item State-Trait Anxiety Inventory (STAI-6) 65 Minutes (Pre-Script #2)
Description
Six-item State-Trait Anxiety Inventory (STAI-6) is a psychological inventory consisting of 6 self-report items on a 4-point Likert scale. The STAI-6 measures state anxiety. Higher scores are positively correlated with higher levels of anxiety. STAI-6 scores are classified as "no or low anxiety" (6-12), "moderate anxiety" (13-18), and "high anxiety" (19-24). (minimum score of 6 to a maximum score of 24)
Time Frame
65 minutes
Title
Six-item State-Trait Anxiety Inventory (STAI-6) 80 Minutes (Post-Script #2)
Description
Six-item State-Trait Anxiety Inventory (STAI-6) is a psychological inventory consisting of 6 self-report items on a 4-point Likert scale. The STAI-6 measures state anxiety. Higher scores are positively correlated with higher levels of anxiety. STAI-6 scores are classified as "no or low anxiety" (6-12), "moderate anxiety" (13-18), and "high anxiety" (19-24). (minimum score of 6 to a maximum score of 24)
Time Frame
80 minutes
Title
Six-item State-Trait Anxiety Inventory (STAI-6) (STAI-6) 95 Minutes (Post-Recovery #2)
Description
Six-item State-Trait Anxiety Inventory (STAI-6) is a psychological inventory consisting of 6 self-report items on a 4-point Likert scale. The STAI-6 measures state anxiety. Higher scores are positively correlated with higher levels of anxiety. STAI-6 scores are classified as "no or low anxiety" (6-12), "moderate anxiety" (13-18), and "high anxiety" (19-24). (minimum score of 6 to a maximum score of 24)
Time Frame
95 minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Men and women ages 21 to 60; Current diagnosis of AD and PTSD; Drink regularly are not in an active phase of alcohol withdrawal; Not at risk for suicide; Not taking regularly psychoactive drugs including anxiolytics and antidepressants; For women, have regular menses every 25-35 days. Exclusion Criteria: Current SCID diagnosis of any psychotic disorder; Substance dependence (other than alcohol and nicotine) in the past 30 days; Current unstable medical condition; Positive test results at more than one baseline appointment on urine drug screens conducted for opiates, cocaine, marijuana, benzodiazepines, and barbiturates; for women, amenorrhea, use of oral contraceptives; Known allergy to progesterone or peanuts (vehicle for micronized progesterone); History of thrombophlebitis, deep vein thrombosis, pulmonary embolus, clotting or Bleeding disorders, heart disease, diabetes or history of stroke.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elizabeth Ralevski, Ph.D.
Organizational Affiliation
Yale University
Official's Role
Principal Investigator
Facility Information:
Facility Name
VA Connecticut Healtcase System
City
West Haven
State/Province
Connecticut
ZIP/Postal Code
06516
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Progesterone Effect on Individuals Diagnoses With AD and PTSD.

We'll reach out to this number within 24 hrs